CTx36 Kit, contains three tubes of CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 o...
FDA Drug Recall #D-0457-2022 — Class III — December 3, 2021
Recall Summary
| Recall Number | D-0457-2022 |
| Classification | Class III — Low risk |
| Date Initiated | December 3, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Dental Alliance Holdings LLC |
| Location | Albany, OR |
| Product Type | Drugs |
| Quantity | 90 single tubes of 352110 and 315 single tubes of 352111 |
Product Description
CTx36 Kit, contains three tubes of CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 oz (57 g) Rx only NDC: 61578-205-01 Manufactured by Oral BioTech Albany, Oregon 97321 and six boxes of 4fl.oz. Carifree CTx4 Treatment Rinse.
Reason for Recall
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
Distribution Pattern
Distributed nationwide with the United States
Lot / Code Information
Lot #: 352110, 352111 Exp. Date 06/22; (contains recalled CariFree CTx4 5000 gel tube lot 142017)
Other Recalls from Dental Alliance Holdings LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0454-2022 | Class III | CTx7 Kit, contains one tube CariFree CTx4 Gel 5... | Dec 3, 2021 |
| D-0458-2022 | Class III | CariFree sample boxes, contains one tube of Car... | Dec 3, 2021 |
| D-0459-2022 | Class III | CTx12 5000 Kit which contains 3 boxes of CariFr... | Dec 3, 2021 |
| D-0455-2022 | Class III | CTx21 Kit, contains three tubes of CariFree CT... | Dec 3, 2021 |
| D-0453-2022 | Class III | CariFree CTx4 GEl 5000 1.1% Neutral Sodium Fluo... | Dec 3, 2021 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.